epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Panlor SS
    acetaminophen/ caffeine/ dihydrocodeine
  • remove Sudafed PE Sinus Congestion Night
    diphenhydramine/ phenylephrine
  • remove Tepezza (teprotumumab-trbw)
    teprotumumab

multicheck MultiCheck Results - 2 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face Panlor SS (acetaminophen/ caffeine/ dihydrocodeine) + Sudafed PE Sinus Congestion Night (diphenhydramine/ phenylephrine)

Avoid/Use Alternative


dihydrocodeine + diphenhydramine

use alternative or monitor respiratory rate, withdrawal sx; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. dihydrocodeine levels, risk of profound CNS and respiratory depression, psychomotor impairment, severe constipation, paralytic ileus, urinary retention, other adverse effects; may decr. active metabolite dihydromorphine levels, efficacy (hepatic metabolism inhibited, decr. conversion to dihydromorphine, additive effects)

Monitor/Modify Tx


caffeine + phenylephrine

monitor BP, HR; avoid excessive caffeine intake: combo may incr. risk of HTN, tachycardia (additive effects)

Additional Considerations

Smiley face Smiley face dihydrocodeine in Panlor SS

consider prescribing an opioid overdose reversal agent, especially with concomitant CNS depressant use

Smiley face Smiley face phenylephrine in Sudafed PE Sinus Congestion Night

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information